IDENTIFICATION OF T(11;14)(Q13;Q32) IN VARIOUS HEMATOPOIETIC LINEAGES OF MANTLE CELL LYMPHOMA PATIENTS. JOINT APPLICATION OF FLUORESCENCE-ACTIVATED CELL SORTING AND FLUORESCENCE IN SITU HYBRIDIZATION

被引:0
|
作者
Vorobiev, V. [1 ]
Gretsov, E. [1 ]
Obukhova, T. [1 ]
Domracheva, E. [1 ]
Lorie, Y. [1 ]
Zherebtsova, V. [1 ]
Vorobjev, I. [1 ]
机构
[1] Natl Res Ctr Hematol, Moscow, Russia
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1540
引用
收藏
页码:610 / 610
页数:1
相关论文
共 50 条
  • [21] Translocation (11;14)(q13;q32) and preferential involvement of chromosomes 1, 2, 9, 13, and 17 in mantle cell lymphoma
    Espinet, B
    Solé, F
    Woessner, S
    Bosch, F
    Florensa, L
    Campo, E
    Costa, D
    Lloveras, E
    Vilà, RM
    Besses, C
    Montserrat, E
    Sans-Sabrafen, J
    CANCER GENETICS AND CYTOGENETICS, 1999, 111 (01) : 92 - 98
  • [22] PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32)
    Sato, Kazuyuki
    Sakai, Hirotaka
    Kato, Masayuki
    Nishio, Yuji
    Tsuruoka, Yuka
    Uemura, Yu
    Yokoi, Satoshi
    Saito, Tasuku
    Matsunawa, Manabu
    Suzuki, Yoshinori
    Isobe, Yasushi
    Inoue, Yasuyuki
    Takahashi, Masatomo
    Miura, Ikuo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (06) : 608 - 611
  • [23] High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies
    Avet-Loiseau, H
    Li, JY
    Facon, T
    Brigaudeau, C
    Morineau, N
    Maloisel, F
    Rapp, MJ
    Talmant, P
    Trimoreau, F
    Jaccard, A
    Harousseau, JL
    Bataille, R
    CANCER RESEARCH, 1998, 58 (24) : 5640 - 5645
  • [24] CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: A case report
    Yoo, Seol-Bong
    Kim, Young A.
    Jeon, Yoon Kyung
    Kim, Chul-Woo
    PATHOLOGY RESEARCH AND PRACTICE, 2008, 204 (10) : 779 - 783
  • [25] PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32)
    Kazuyuki Sato
    Hirotaka Sakai
    Masayuki Kato
    Yuji Nishio
    Yuka Tsuruoka
    Yu Uemura
    Satoshi Yokoi
    Tasuku Saito
    Manabu Matsunawa
    Yoshinori Suzuki
    Yasushi Isobe
    Yasuyuki Inoue
    Masatomo Takahashi
    Ikuo Miura
    International Journal of Hematology, 2015, 101 : 608 - 611
  • [26] Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms
    Chen, Yi-Hua
    Gao, Juehua
    Fan, Guang
    Peterson, LoAnn C.
    MODERN PATHOLOGY, 2010, 23 (01) : 105 - 112
  • [27] High incidence of translocations t(11;14) (q13;q32) and t(4;14) (p16;q32) in patients with plasma cell malignancies.
    Avet-Loiseau, H
    Li, JY
    Facon, T
    Brigaudeau, C
    Morineau, N
    Maloisel, F
    Rapp, MJ
    Talmant, P
    Trimoreau, F
    Jaccard, A
    Harousseau, JL
    Bataille, R
    BLOOD, 1998, 92 (10) : 716A - 717A
  • [28] Immunophenotypic and laboratory features of t(11;14)(q13;q32)-positive plasma cell neoplasms
    Shi, Min
    Ternus, Jessica A.
    Ketterling, Rhett P.
    Jevremovic, Dragan
    McPhail, Ellen D.
    LEUKEMIA & LYMPHOMA, 2018, 59 (08) : 1913 - 1919
  • [29] MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32)
    Coccaro, Nicoletta
    Tota, Giuseppina
    Anelli, Luisa
    Zagaria, Antonella
    Casieri, Paola
    Cellamare, Angelo
    Minervini, Crescenzio Francesco
    Minervini, Angela
    Cumbo, Cosimo
    Impera, Luciana
    Brunetti, Claudia
    Orsini, Paola
    Parciante, Elisa
    Mestice, Anna
    Specchia, Giorgina
    Albano, Francesco
    ONCOLOGY LETTERS, 2016, 12 (02) : 1460 - 1464
  • [30] Myeloma (MM) and the t(11;14)(q13;q32); Increasing evidence for a biologically distinct subset of patients.
    Fonseca, R
    Harrington, D
    Oken, MM
    Hoyer, JD
    Dewald, GW
    Bailey, RJ
    Van Wier, SA
    Henderson, KJ
    Kay, NE
    van Ness, B
    Blood, EA
    Greipp, PR
    BLOOD, 2000, 96 (11) : 151A - 151A